TrialDiabetes care2024

Efficacy and Safety of LX9211 for Relief of Diabetic Peripheral Neuropathic Pain (RELIEF-DPN 1): Results of a Double-Blind, Randomized, Placebo-Controlled, Proof-of-Concept Study.

Rodica Pop-Busui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.